/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | TMDXTransMedics Group, I |
|---|---|
| Last close | $88.58 |
| Change % | -1.18% |
| Market cap | $3.1B |
| P/E | 18.2 |
| Revenue | $605M |
| Rev growth (YoY) | 37.1% |
| Net income | $190M |
| Net margin | 31.4% |
| EPS (diluted) | $4.87 |
| Piotroski F-ScoreUNVALIDATED | 7 |
| Altman Z-ScoreUNVALIDATED | 4.25 |
| Beneish M-ScoreUNVALIDATED | -1.44 |
| Next earnings | 10-23 → 11-02 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.